Product Name   :    Repaglinide 1.32% DC Granules
Dosage Form   :    Tablets
Dose   :    2mg
Reference Product   :    Prandin
API : DMF; Dossier — CTD   :    Available
Originator   :    Boehringer Ingelheim
Metformin mainly inhibits hepatic gluconeogenesis and shows a hypoglycemic effect without affecting insulin secretion from pancreatic ??cells. It also promotes glucose uptake in peripheral tissues and controls glucose absorption in the small intestine.
Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus.[1] The mechanism of action of repaglinide involves promoting insulin release from ?-islet cells of the pancreas; like other antidiabetic drugs, a main side effect concern is hypoglycemia.